Current Hypogonadism Treatment Options
Abstract: Treatment for hypogonadism is increasing, particularly in the senior population, but low testosterone levels are also on the rise in young men. Hypogonadism treatment represents a unique challenge to clinicians due to label warnings and the negative stigma of being diagnosed and treated for testosterone deficiency. Recent studies of testosterone formulations are showing promising data results of a reduction in adverse impacts. Recent studies have also shown that treating low
testosterone is important to significantly reducing the associated risk of diabetes, obesity, metabolic syndrome, osteoporosis, and cardiovascular problems. Physicians need to consider these updated studies and testosterone formula options to educate patients and provide them with a safe and effective testosterone therapy.